Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China flag China · Delayed Price · Currency is CNY
16.23
-0.16 (-0.98%)
At close: Feb 13, 2026

SHA:688526 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
1,005933.041,027974.141,083835
Other Revenue
8.888.8837.1427.1219.868.23
1,014941.921,0641,0011,103843.23
Revenue Growth (YoY)
12.43%-11.48%6.27%-9.22%30.81%66.15%
Cost of Revenue
364.7360.45321.43279.05230.42151.17
Gross Profit
649.58581.48742.65722.22872.6692.06
Selling, General & Admin
159.99169.4213.2219.26201.91153.06
Research & Development
96.8486.1288.51102.758059.08
Other Operating Expenses
4.86-0.93-0.826.295.923.95
Operating Expenses
237.95266.47385.36339.01296.9223.43
Operating Income
411.62315.01357.29383.21575.71468.63
Interest Expense
-0.49-4.77-8.16-5.45-1.81-0.43
Interest & Investment Income
56.6173.1794.1275.6971.8637.32
Currency Exchange Gain (Loss)
000.05---
Other Non Operating Income (Expenses)
-0.87-0.72-0.21-0.2-0.27-0.36
EBT Excluding Unusual Items
466.87382.69443.1453.25645.48505.16
Impairment of Goodwill
-3.31-3.31----
Gain (Loss) on Sale of Investments
31.8630.99-10.191.44--
Gain (Loss) on Sale of Assets
-0.750.93----0.59
Asset Writedown
8.84-0.53-1.72-0.14-1.57-
Legal Settlements
----0.82-2.78
Other Unusual Items
26.7827.3626.3912.0615.3217.87
Pretax Income
530.29438.13457.58466.61660.05519.66
Income Tax Expense
72.2156.646257.4689.4171.86
Earnings From Continuing Operations
458.09381.49395.58409.15570.64447.8
Minority Interest in Earnings
1.450.860.350.370.11-
Net Income
459.54382.35395.93409.52570.74447.8
Net Income to Common
459.54382.35395.93409.52570.74447.8
Net Income Growth
53.64%-3.43%-3.32%-28.25%27.45%84.55%
Shares Outstanding (Basic)
469466466465464386
Shares Outstanding (Diluted)
469466466465464386
Shares Change (YoY)
0.52%0.10%0.10%0.29%20.20%6.59%
EPS (Basic)
0.980.820.850.881.231.16
EPS (Diluted)
0.980.820.850.881.231.16
EPS Growth
52.84%-3.53%-3.41%-28.46%6.03%73.13%
Free Cash Flow
314.49285.74433.53320.86156.82288.54
Free Cash Flow Per Share
0.670.610.930.690.340.75
Dividend Per Share
0.4300.4300.4300.1900.1900.290
Dividend Growth
--126.32%--34.48%-
Gross Margin
64.04%61.73%69.79%72.13%79.11%82.07%
Operating Margin
40.58%33.44%33.58%38.27%52.19%55.58%
Profit Margin
45.31%40.59%37.21%40.90%51.74%53.11%
Free Cash Flow Margin
31.01%30.34%40.74%32.05%14.22%34.22%
EBITDA
516.09423.23470.54480.16638.35505.66
EBITDA Margin
50.88%44.93%44.22%47.95%57.87%59.97%
D&A For EBITDA
104.46108.22113.2496.9562.6437.03
EBIT
411.62315.01357.29383.21575.71468.63
EBIT Margin
40.58%33.44%33.58%38.27%52.19%55.58%
Effective Tax Rate
13.62%12.93%13.55%12.31%13.55%13.83%
Revenue as Reported
1,014941.921,0641,0011,103843.23
Advertising Expenses
-25.734.12.872.965.49
Source: S&P Global Market Intelligence. Standard template. Financial Sources.